Methods and Prospects of 3d Printing in Pharmaceuticals

Abstract

The FDA gave its initial permission to 3D printing in the year 2016. There are numerous approaches to 3D printing, the
most common of which are the powder-based method, the binder deposition method, stereolithography, and the inkjet
printing method. 3DP has evolved into one of the most comprehensive and potent tools available to serve as a technology
for the fabrication of developed dosage forms. Include in this article the regulatory agencies that are in charge of putting in
place such systems for the production of drug items. Three-dimensional printing (3DP) makes it possible to generate
multiple geometries for pharmaceutical drug delivery drugs through the use of computer-aided designs employing a variety
of processes and materials. It provided a concise summary of the recent accomplishments of the manufacturing sector in
the field of biomedical and pharmaceutical research.